These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 27503401

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation.
    Lu R, Huang R, Li K, Zhang X, Yang H, Quan Y, Li Q.
    Am J Ophthalmol; 2014 Mar; 157(3):591-7.e1-2. PubMed ID: 24269849
    [Abstract] [Full Text] [Related]

  • 4. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N, Bilen Ş, Topçu Yılmaz P, Evren Kemer Ö.
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI, Shin HM, Lee SY, Lew H.
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [Abstract] [Full Text] [Related]

  • 7. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 8. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC, Oliveira GC, Cariello AJ, Felberg S, Osaki MH.
    Arq Bras Oftalmol; 2010 Aug; 73(5):405-8. PubMed ID: 21225122
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relations between nonmotor manifestations and motor disorders in patients with benign essential blepharospasm.
    Zhou Y, Wang W, Lin Z, Lin T, Gong L.
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3615-3623. PubMed ID: 37341835
    [Abstract] [Full Text] [Related]

  • 12. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
    Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.
    Arq Bras Oftalmol; 2006 Dec; 69(3):319-22. PubMed ID: 16936952
    [Abstract] [Full Text] [Related]

  • 13. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
    Kocabeyoglu S, Sekeroglu HT, Mocan MC, Muz E, Irkec M, Sanac AS.
    Eur J Ophthalmol; 2014 Dec; 24(6):830-4. PubMed ID: 24803156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
    Choi MG, Yeo JH, Kang JW, Chun YS, Lee JK, Kim JC.
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
    [Abstract] [Full Text] [Related]

  • 16. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M, Schiavi C, Taroni L, Sebastiani S, Bernabei F, Roda M, Moscardelli F, Giannaccare G.
    Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
    [Abstract] [Full Text] [Related]

  • 17. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT.
    Sci Rep; 2018 May 30; 8(1):8367. PubMed ID: 29849166
    [Abstract] [Full Text] [Related]

  • 18. Tear osmolarity, dry eye syndrome, blepharospasm and botulinum neurotoxin.
    Girard B, de Saint Sauveur G.
    J Fr Ophtalmol; 2021 Dec 30; 44(10):1553-1559. PubMed ID: 34756743
    [Abstract] [Full Text] [Related]

  • 19. Dry eye syndrome in benign essential blepharospasm.
    Girard BC, Lévy P.
    J Fr Ophtalmol; 2019 Dec 30; 42(10):1062-1067. PubMed ID: 31733914
    [Abstract] [Full Text] [Related]

  • 20. [Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].
    Yabiku MM, Sartori Jde F, Sarraff EP, Osaki TH, Hossaka SK, Pereira CI, Freitas Wd, Osaki MH, Cariello AJ.
    Arq Bras Oftalmol; 2011 Dec 30; 74(6):414-6. PubMed ID: 22331113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.